EE03876B1 - Aminohappe estrit sisaldavad asool-antimükootikumid, nende valmistamine ja kasutamine ning neid sisaldavad farmatseutilised kompositsioonid - Google Patents

Aminohappe estrit sisaldavad asool-antimükootikumid, nende valmistamine ja kasutamine ning neid sisaldavad farmatseutilised kompositsioonid

Info

Publication number
EE03876B1
EE03876B1 EEP199900100A EEP9900100A EE03876B1 EE 03876 B1 EE03876 B1 EE 03876B1 EE P199900100 A EEP199900100 A EE P199900100A EE P9900100 A EEP9900100 A EE P9900100A EE 03876 B1 EE03876 B1 EE 03876B1
Authority
EE
Estonia
Prior art keywords
preparation
amino acids
pharmaceutical compositions
compositions containing
antimycotic agents
Prior art date
Application number
EEP199900100A
Other languages
English (en)
Estonian (et)
Inventor
Meerpoel Lieven
Heeres Jan
Jozef Maria Hendrickx Robert
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of EE9900100A publication Critical patent/EE9900100A/xx
Publication of EE03876B1 publication Critical patent/EE03876B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
EEP199900100A 1997-02-11 1998-02-03 Aminohappe estrit sisaldavad asool-antimükootikumid, nende valmistamine ja kasutamine ning neid sisaldavad farmatseutilised kompositsioonid EE03876B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97200374 1997-02-11
EP97203228 1997-10-15
PCT/EP1998/000646 WO1998034934A1 (en) 1997-02-11 1998-02-03 Amino acid ester containing azole antifungals

Publications (2)

Publication Number Publication Date
EE9900100A EE9900100A (et) 1999-10-15
EE03876B1 true EE03876B1 (et) 2002-10-15

Family

ID=26146124

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900100A EE03876B1 (et) 1997-02-11 1998-02-03 Aminohappe estrit sisaldavad asool-antimükootikumid, nende valmistamine ja kasutamine ning neid sisaldavad farmatseutilised kompositsioonid

Country Status (31)

Country Link
US (3) US6262052B1 (ru)
EP (1) EP0958289B1 (ru)
JP (1) JP4347911B2 (ru)
KR (1) KR100509171B1 (ru)
CN (1) CN1238353C (ru)
AT (1) ATE270290T1 (ru)
AU (1) AU725302C (ru)
BG (1) BG63872B1 (ru)
BR (1) BR9809744A (ru)
CA (1) CA2262791C (ru)
CZ (1) CZ297197B6 (ru)
DE (1) DE69824834T2 (ru)
DK (1) DK0958289T3 (ru)
EE (1) EE03876B1 (ru)
ES (1) ES2224364T3 (ru)
HU (1) HU227744B1 (ru)
ID (1) ID21755A (ru)
IL (2) IL128513A (ru)
MY (1) MY129537A (ru)
NO (1) NO316668B1 (ru)
NZ (1) NZ334477A (ru)
PL (1) PL191152B1 (ru)
PT (1) PT958289E (ru)
RU (1) RU2197489C2 (ru)
SI (1) SI0958289T1 (ru)
SK (1) SK284910B6 (ru)
TR (1) TR199900584T2 (ru)
TW (1) TW495508B (ru)
UA (1) UA61919C2 (ru)
WO (1) WO1998034934A1 (ru)
ZA (1) ZA981079B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957101A1 (en) * 1998-05-14 1999-11-17 Janssen Pharmaceutica N.V. Water soluble azoles as broad-spectrum antifungals
AU1915500A (en) 1998-11-20 2000-06-13 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
EE200100575A (et) * 1999-05-04 2003-02-17 Janssen Pharmaceutica N.V. Seentevastased eetrid, nende valmistamismeetod jakasutamine, kompositsioon ja selle valmistamismeetod
US20060199778A1 (en) * 2001-09-19 2006-09-07 Rutledge Ellis-Behnke Methods and products related to non-viral transfection
ITMI20032020A1 (it) * 2003-10-17 2005-04-18 Italfarmaco Spa Nuovi agenti antifungini azolici con diminuita interazione con i citocromi metabolici
WO2011144653A1 (en) * 2010-05-19 2011-11-24 Sandoz Ag Process for the preparation of chiral triazolones
CA2972405A1 (en) 2014-12-30 2016-07-07 Dow Agrosciences Llc Use of picolinamide compounds as fungicides
BR102019004480B1 (pt) * 2018-03-08 2023-03-28 Dow Agrosciences Llc Picolinamidas como fungicidas
CN111138421A (zh) * 2019-12-26 2020-05-12 上海英诺富成生物科技有限公司 抗真菌水溶性化合物及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218458A (en) 1978-06-23 1980-08-19 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4791111A (en) * 1985-12-23 1988-12-13 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties
US4916134A (en) 1987-03-25 1990-04-10 Janssen Pharmacuetica N.V. 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones
CA1331757C (en) 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
PL172358B1 (en) 1992-03-18 1997-09-30 Janssen Pharmaceutica Nv Stereoisomeric form of itraconazole or saperconazole and method of obtaining same
AU681753B2 (en) 1993-12-21 1997-09-04 Merck Sharp & Dohme Corp. Tetrahydrofuran antifungals
NZ278882A (en) * 1994-01-24 1997-06-24 Janssen Pharmaceutica Nv Piperazine-containing azole antifungal compounds
ATE240319T1 (de) 1995-06-02 2003-05-15 Schering Corp Antifungale tetrahydrofurane
WO1997000255A1 (en) * 1995-06-19 1997-01-03 Schering Corporation Tetrahydrofuran antifungals

Also Published As

Publication number Publication date
BR9809744A (pt) 2000-06-20
IL128513A (en) 2002-11-10
CZ283599A3 (cs) 2000-02-16
CN1238353C (zh) 2006-01-25
AU725302B2 (en) 2000-10-12
MY129537A (en) 2007-04-30
PT958289E (pt) 2004-11-30
ID21755A (id) 1999-07-22
NO990484L (no) 1999-10-11
HUP0001050A3 (en) 2001-07-30
US6703506B2 (en) 2004-03-09
DK0958289T3 (da) 2004-11-01
WO1998034934A1 (en) 1998-08-13
US20010039281A1 (en) 2001-11-08
TR199900584T2 (xx) 1999-10-21
CA2262791C (en) 2008-10-28
NZ334477A (en) 2001-05-25
SK105999A3 (en) 2000-06-12
CZ297197B6 (cs) 2006-09-13
JP4347911B2 (ja) 2009-10-21
BG103171A (en) 1999-09-30
IL149285A0 (en) 2002-11-10
AU6620798A (en) 1998-08-26
NO990484D0 (no) 1999-02-02
ATE270290T1 (de) 2004-07-15
HUP0001050A2 (hu) 2001-04-28
HU227744B1 (en) 2012-02-28
DE69824834T2 (de) 2005-07-21
US20030158210A1 (en) 2003-08-21
ZA981079B (en) 1999-08-10
US6512116B2 (en) 2003-01-28
PL332008A1 (en) 1999-08-16
KR100509171B1 (ko) 2005-08-22
SK284910B6 (sk) 2006-02-02
US6262052B1 (en) 2001-07-17
BG63872B1 (bg) 2003-04-30
RU2197489C2 (ru) 2003-01-27
TW495508B (en) 2002-07-21
CN1236366A (zh) 1999-11-24
AU725302C (en) 2001-08-23
IL149285A (en) 2007-08-19
DE69824834D1 (de) 2004-08-05
EP0958289B1 (en) 2004-06-30
SI0958289T1 (en) 2004-12-31
IL128513A0 (en) 2000-01-31
JP2001508080A (ja) 2001-06-19
EP0958289A1 (en) 1999-11-24
EE9900100A (et) 1999-10-15
PL191152B1 (pl) 2006-03-31
ES2224364T3 (es) 2005-03-01
KR20000068526A (ko) 2000-11-25
NO316668B1 (no) 2004-03-29
CA2262791A1 (en) 1998-08-13
UA61919C2 (ru) 2003-12-15

Similar Documents

Publication Publication Date Title
RU95101048A (ru) Производные пролинамида, фармкомпозиция на их основе
ATE61050T1 (de) Pyridazinamine wirksam gegen viren.
IL100015A0 (en) Mono-n-substituted 1,4,7,10-tetraazacyclododecane derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
FR2743562B1 (fr) Derives de n-(arylsulfonyl) aminoacides, leur preparation, les compositions pharmaceutiques en contenant
NO920035L (no) Trifluormetylketon-derivater, og deres fremstilling og anvendelse
DK529888A (da) Substituerede n-(1-alkyl-3-hydroxy-4-piperidinyl) benzamider
DK581889A (da) Antiatherosclerotiske diarylforbindelser
EE03876B1 (et) Aminohappe estrit sisaldavad asool-antimükootikumid, nende valmistamine ja kasutamine ning neid sisaldavad farmatseutilised kompositsioonid
DE69819539D1 (de) Antithrombotische mittel
BR9807330A (pt) Agentes inibidores do progresso de pterìgio e recorrência pós-operatória do mesmo
DE69330601D1 (de) Serotoninergische ergolin derivate
EP1027051A4 (en) ANTITHROMBOTIC AGENTS
ATE248163T1 (de) Neuartige, pharmazeutisch aktive verbindung
NO950177D0 (no) Farmakologisk aktive erivater
ATE268768T1 (de) Antithrombosemittel

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231